在接受密集化疗的急性骨髓性白血病患者中,用低剂量松酸进行预防
Søren Thorgaard Bønløkke1,2, Marianne Tang Severinsen3,4, Hans Beier Ommen5,2
1Department of Clinical Biochemistry Aarhus University Hospital Aarhus N Denmark.
EJHaem
|August 21, 2023
概括
低剂量的特兰胺酸 (TXA) 在急性髓性白血病 (AML) 患有血小板缺血的患者中研究出血减少. 该研究发现TXA是安全的,但没有显示出出血发作或出血日数的显著减少.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性髓性白血病 (AML) 患者经常经历严重的血小板缺血,增加出血风险.
- 尽管进行了预防性血小板输血,但大量出血仍然是AML治疗的挑战.
- 像特兰胺酸 (TXA) 这样的抗纤维素解药物用于各种患者群体的血液静止.
研究的目的:
- 为了研究低剂量特兰胺酸 (TXA) 在降低血出并发症的功效,在血栓塞性AML患者.
- 为了比较接受TXA和不接受TXA的AML患者之间的出血发生率,严重程度和血栓塞栓事件.
主要方法:
- 这是一项涉及113名血栓细胞缩性AML患者的比较研究.
- 患者被分为两组:一个接受TXA (每天三次500毫克),一个没有TXA的对照组.
- 从电子医疗记录和实验室系统中收集出血,血栓和输血的数据.
主要成果:
- 在患有出血事件的患者数量中没有显著差异 (89%的TXA与93%的无TXA).
- 平均出血日数 (2.5对2.0) 和输血需求在各组之间没有显著差异.
- 血小板计数低于5×10^9/L是出血的重要危险因素 (p < 0.01).
- 在TXA和无TXA组之间没有注意到血栓栓塞事件的差异 (8%vs10%).
结论:
- 低剂量的特兰胺酸 (TXA) 是安全的用于血栓塞性AML患者.
- 这项研究没有发现证据表明TXA可以减少该患者群体的出血.
- 血小板数仍然是影响AML患者出血风险的关键因素.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
751
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
751
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


